SOGA2 Antikörper (AA 13-202)
Kurzübersicht für SOGA2 Antikörper (AA 13-202) (ABIN2963477)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 13-202
- 
                                            Spezifität
- Reacts with the region between residues 13 to 202 of human MTCL1
- 
                                            Aufreinigung
- Purified
- 
                                            Immunogen
- Recombinant protein fragment corresponding to the region within amino acids 13 and 202 of human KIAA0802.
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        Working dilution: Optimal dilution should be determined by the end user. 
 The following are guidelines only:
 ELISA: 1:20000 - 1:80000 IHC - P: 10 μg/mL WB: 1:1000 - 1:2000
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1 mg/mL
- 
                                            Buffer
- PBS, pH 7.4, Sodium azide 0.02 %
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Aliquot and store at -20°C. Avoid repeated freezing and thawing.
 
- 
                                            
- 
    - SOGA2 (SOGA Family Member 2 (SOGA2))
- 
                                            Andere Bezeichnung
- MTCL1
- 
                                            Gen-ID
- 23255
 Target
- 
                    
 
                                     
                                     
                                    